
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
In 2015, Pionyr Immunotherapeutics embarked on a journey to forge a new path in immuno-oncology for patients in need. We are a clinical stage company discovering and developing novel antibody therapeutics that dramatically alter the tumor microenvironment (TME) and enhance the bodys immune defense against cancer with the potential to eliminate it. Pionyrs Myeloid TuningTM cutting-edge technology is based on the discovery that tuning the tumor microenvironment to favor immune-activating cells and disable immune-suppressing cells improves the bodys ability to combat cancer, particularly in combination with checkpoint inhibitors. Additionally, Pionyr is building a pipeline of transmembrane and intracellular targets using...
Immuno-oncology,myeloid tuning,myeloid biology,and translational research
Pionyr immunotherapeutics operates in the Biotechnology industry.
Pionyr immunotherapeutics's revenue is 11m - 100m
Pionyr immunotherapeutics has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.